Jonathan R. Evans
University of Nottingham
36 Papers
51 Citations
Jonathan R. Evans is an academic researcher from University of Nottingham. The author has contributed to research in topics: Medicine & Parkinson's disease. The author has an hindex of 21, co-authored 33 publications. Previous affiliations of Jonathan R. Evans include Nottingham University Hospitals NHS Trust & Haukeland University Hospital.
Chat about Author
Papers
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Caroline H. Williams-Gray,Jonathan R. Evans,An Goris,An Goris,Thomas Foltynie,Maria Ban,Trevor W. Robbins,Carol Brayne,Bhaskar Kolachana,Daniel R. Weinberger,Stephen Sawcer,Roger A. Barker +11 more
TL;DR: The work suggests that the dementing process in Parkinson's disease is predictable and related to tau while frontal-executive dysfunction evolves independently with a more dopaminergic basis and better prognosis.
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Caroline H. Williams-Gray,Sarah L Mason,Jonathan R. Evans,Thomas Foltynie,Carol Brayne,Trevor W. Robbins,Roger A. Barker +6 more
TL;DR: The CamPaIGN study as mentioned in this paper has been the first to prospectively track disease evolution from diagnosis in an unselected population-representative incident cohort, focusing on three key irreversible milestones: postural instability (Hoehn and Yahr 3), dementia and death.
630
Evaluation of and Treatment for Monosymptomatic Enuresis: A Standardization Document From the International Children's Continence Society
Tryggve Nevéus,Paul Eggert,Jonathan R. Evans,Antonio Macedo,Søren Rittig,Serdar Tekgul,Johan Vande Walle,Chung-Kwong Yeung,Lane Robson +8 more
TL;DR: Enuresis in a child older than 5 years is not a trivial condition, and needs proper evaluation and treatment, and requires time but usually does not demand costly or invasive procedures.
387
A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
Vincent Plagnol,Mike A. Nalls,Jose Bras,Dena G. Hernandez,Dena G. Hernandez,M. Sharma,Una-Marie Sheerin,Mohamad Saad,Javier Simón-Sánchez,Claudia Schulte,Suzanne Lesage,Suzanne Lesage,Sigurlaug Sveinbjörnsdóttir,Philippe Amouyel,Philippe Amouyel,S. Arepalli,Roger A. Barker,C. Bellinguez,Yoav Ben-Shlomo,Henk W. Berendse,Daniela Berg,Kailash P. Bhatia,R. M. A. de Bie,Alessandro Biffi,Alessandro Biffi,B.R. Bloem,Zoltán Bochdanovits,Michael Bonin,Knut Brockmann,J. Brooks,David J. Burn,Gavin Charlesworth,Honglei Chen,Patrick F. Chinnery,Sean Chong,Carl E Clarke,Carl E Clarke,Mark R. Cookson,J. M. Cooper,Jean-Christophe Corvol,Carl Counsell,P. Damier,J. F. Dartigues,Panagiotis Deloukas,Günther Deuschl,David T. Dexter,K.D. van Dijk,Allissa Dillman,F. Durif,Alexandra Durr,Sarah Edkins,Jonathan R. Evans,Thomas Foltynie,Colin Freeman,Jianjun Gao,M. Gardner,J. R. Gibbs,J. R. Gibbs,A. Goate,Emma Gray,Rita Guerreiro,O. Gustafsson,Clare Elizabeth Harris,Garrett Hellenthal,J.J. van Hilten,Albert Hofman,Albert R. Hollenbeck,Janice L. Holton,Michele T.M. Hu,X. Huang,Heiko Huber,Gavin Hudson,Sarah E. Hunt,J. Huttenlocher,Thomas Illig,Palmi V. Jonsson,Cordelia Langford,Andrew J. Lees,Peter Lichtner,Patricia Limousin,Grisel Lopez,Delia Lorenz,Alisdair McNeill,C. Moorby,Matthew Moore,Huw R. Morris,Karen E. Morrison,Karen E. Morrison,Ese E. Mudanohwo,Sean S. O'Sullivan,J. P. Pearson,R. Pearson,Joel S. Perlmutter,H. Petursson,Matti Pirinen,Pierre Pollak,Bart Post,Simon C. Potter,Bernard Ravina,Tamas Revesz,O. Riess,Fernando Rivadeneira,Patrizia Rizzu,Mina Ryten,Stephen Sawcer,Peter Heutink,Nicholas W. Wood +106 more
TL;DR: Using a dataset of post-mortem brain samples assayed for gene expression and methylation, methylation and expression changes associated with PD risk variants in PARK16/1q32, GPNMB/7p15, and STX1B/16p11 loci are identified, suggesting potential molecular mechanisms and candidate genes at these risk loci.
Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
Sophie Winder-Rhodes,Jonathan R. Evans,Maria Ban,Sarah L Mason,Caroline H. Williams-Gray,Thomas Foltynie,Raquel Duran,Niccolo E. Mencacci,Stephen Sawcer,Roger A. Barker +9 more
TL;DR: It is shown that in a representative, unselected UK Parkinson's disease population, GBA mutations are present at a frequency of 3.5%.